Together, these data show that B7-H3 expression by cancer cells in ampullary cancer patients is associated with better post-surgical disease course independent of tumor characteristics, but should not be used as a prognostic biomarker because CA19-9 levels have a better prognostic value. This evidence concerns the gene CD276 and cancer.